The Academy of Medical Sciences and National Academy of Science of Sri Lanka convened a policy workshop on non-communicable diseases in South Asia and beyond in Sri Lanka on the 23-24 January 2020.
Status: Ongoing
Read more
This platform aims to join-up and share helpful resources relevant to research on the global health challenge of multimorbidity. It is intended for anyone interested in contributing to a much needed step-change in the understanding of the trends, clusters, mechanisms and causes, burden, prevention, and management of multiple long-term conditions through research.
Status:
Read more
The Academy of Medical Sciences and InterAcademy Partnership convened a policy workshop on research and Universal Health Coverage in low and middle income countries in London on the 29-30 May 2019.
Status: Ongoing
Read more
On Monday 4 and Tuesday 5 February 2019, the Academy of Medical Sciences hosted a two-day meeting on antimicrobial resistance (AMR). The meeting was organised as part of a wider programme of work which aims to strengthen the research links between the UK and India to jointly address the challenge of AMR.
Status: Launched
Read more
On Thursday 29 November 2018, the Academy of Medical Sciences and the French Académie Nationale de Médecine held a one-day symposium on mental health and addictions. at the Académie Nationale de Médecine in Paris.
Status: Launched
Read more
The Academy of Medical Sciences has launched its report exploring how the interface between academia and the NHS can be enhanced to improve the health and wealth of the UK.
Status: Launched
Read more
The Government has committed to increasing research and development (R&D) spending to 2.4% of GDP within the next 10 years, with a long-term goal of 3%. In this context the National Academies have recognised the need to better understand the benefits that R&I bring to the UK and how those benefits are achieved.
Status:
Read more
The Academy of Medical Sciences, the Medical Research Council and the National Insitute for Health Research are convening a one-day roundtable on 'Artificial intelligence and health' on 16 January 2019.
Status: Ongoing
Read more
Dr Irene Akua Agyepong delivered the 2018 Academy of Medical Sciences and The Lancet International Health Lecture under the title 'Universal Health Coverage: Global policy agenda breakthrough or great white elephant'?
Status: Launched
Read more
The preclinical-clinical boundary is a key checkpoint in the translational pathway for research. It refers to the point at which preclinical evidence is considered sufficient to merit the move to first-in-human clinical studies, and represents a significant escalation in both resourcing and time, with a high risk of failure. Therefore there is a drive to ensure that the evidence base for progression into clinical studies is as robust and predictive as possible to maximise the chances of success and minimise risk of failure.
Status: Undertaking Follow Up
Read more